5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine(2A), 5-hydroxytryptamine(2B), 5-hydroxytryptamine(2C): Where structure meets function

Pharmacology and Therapeutics

Volumn 79, Issue 3, 1998, Pages 231-257

  Roth, Bryan L ^a   Willins, David L ^a   Kristiansen, Kurt ^a   Kroeze, Wesky K ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT(2A); 5 HT(2C); Molecular model; Serotonin; Signal transduction

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; KETANSERIN; LYSERGIDE; NEUROLEPTIC AGENT; PROTEIN SUBUNIT; PSYCHEDELIC AGENT; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; SCAVENGER; SEROTONIN RECEPTOR; SEROTONIN RECEPTOR AFFECTING AGENT;

AMINO ACID SEQUENCE; ANXIETY; FEEDING BEHAVIOR; HUMAN; LIGAND BINDING; MEMBRANE STRUCTURE; MOOD; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; RECEPTOR BINDING; RECEPTOR DENSITY; REVIEW; SCHIZOPHRENIA; SMOOTH MUSCLE CONTRACTION; STRUCTURE ACTIVITY RELATION; THROMBOCYTE AGGREGATION; CHEMISTRY; METABOLISM; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; FREE RADICAL SCAVENGERS; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGENTS;

EID: 0031595265     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(98)00019-9     Document Type: Review

References (256)

1. 2C receptor as a 60-kDa N-glycosylated protein in choroid plexus and hippocampus. J. Neurochem. 65: 782-790.
2. Aghjanian, G. K., Foote, W. E. and Sheard, M. H. (1968) Lysergic acid diethylamide: sensitive neuronal units in the midbrain raphe. Science 161: 706-708.
3. 2 receptor stimulation. Mol. Pharmacol. 43: 349-355.
4. 2C receptors. J. Neurochem. 64: 2473-2479.
5. 2C receptors. Biol. Psychiatry 39: 1000-1008.
6. 2A receptor. Ser3.36(159) provides a second interaction site for the protonated amine of serotonin but not of lysergic acid diethylamide or bufotenin. J. Biol. Chem. 271: 14672-14675.
7. 2 receptors. J. Med. Chem. 37: 950-962.
8. 2 receptors in rat cerebral cortex. J. Neurochem. 46: 191-197.
9. Arora, K. K., Sakai, A. and Catt, K. J. (1995) Effects of second intracellular loop mutations on signal transduction and internalization of the gonadotropin-releasing hormone receptor. J. Biol. Chem. 270: 22820-22826.
10. 2A receptor gene. Lancet 346: 281-282.
11. 2A receptor and clinical response to clozapine. Neurosci. Lett. 217: 177-178.
12. Bakish, D., Cavazzoni, P., Chudzik, J., Ravindran, A. and Hrdina, P. D. (1997) Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder. Biol. Psychiatry 41: 184-190.
13. Baldwin, J. M. (1993) The probable arrangement of the helices in G protein-coupled receptors. EMBO J. 12: 1693-1703.
14. Baldwin, J. M. (1994) Structure and function of receptors coupled to G proteins. Curr. Opin. Cell Biol. 6: 180-190.
15. Barak, L. S., Tiberi, M., Freedman, N. J., Kwatra, M. M., Lefkowitz, R. J. and Caron, M. G. (1994) A highly conserved tyrosine residue in G protein-coupled receptors is required for agonist-mediated beta 2-adrenergic receptor sequestration. J. Biol. Chem. 269: 2790-2795.
16. Barak, L. S., Menard, L., Ferguson, S. S., Colapietro, A. M. and Caron, M. G. (1995) The conserved seven-transmembrane sequence NP(X)2,3Y of the G-protein-coupled receptor super-family regulates multiple properties of the beta 2-adrenergic receptor. Biochemistry 34: 15407-15414.
17. Barbaccia, M. L., Brunello, N., Chuang, D. M. and Costa, E. (1983) On the mode of action of imipramine: relationship between serotonergic axon terminal function and down-regulation of beta-adrenergic receptors. Neuropharmacology 22: 373-383.
18. 2C receptors reveal novel inverse agonist activity of receptor ligands. J. Biol. Chem. 269: 11687-11690.
19. Bennett, D., Spain, J., Laskowski, M., Roth, B. and Coscia, C. (1985) Stereospecific opiate-binding sites occur in coated vesicles. J. Neurosci. 5: 3010-3015.
20. Benya, R. V., Akeson, M., Mrozinski, J., Jensen, R. T. and Battey, J. F. (1994) Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes. Mol. Pharmacol. 46: 495-501.
21. Berg, K. A., Clarke, W. P., Sailstad, C., Saltzman, A. and Maayani, S. (1994) Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems. Mol. Pharmacol. 46: 477-484.
22. Berridge, M. J., Downes, C. P. and Hanley, M. R. (1982) Lithium amplifies agonist-dependent phosphatidylinositol response in brain and salivary gland. Biochem. J. 206: 587-595.
23. 2A receptor occurs via the endosome pathway in vitro. Mol. Pharmacol. 50: 306-313.
24. Blackshear, M. A. and Sanders-Bush, E. (1982) Serotonin receptor sensitivity after acute and chronic treatment with mianserin. J. Pharmacol. Exp. Ther. 221: 303-308.
25. Blier, P. and de Montigny, C. (1980) Effect of chronic tricylic antidepressant treatment on the serotonergic autoreceptor: a microiontophoretic study in the rat. Naunyn Schmiedebergs Arch. Pharmacol. 314: 123-128.
26. Bohm, S. K., Grady, E. and Bunnett, N. (1997a) Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Biochem. J. 322: 1-18.
27. Bohm, S. K., Khitin, L. M., Smeekens, S. P., Grady, E. F., Payan, D. G. and Bunnett, N. W. (1997b) Identification of potential tyrosine-containing endocytic motifs in the carboxyl-tail and seventh transmembrane domain of the neurokinin 1 receptor. J. Biol. Chem. 272: 2363-2372.
28. Bradley, P. B., Engle, G., Feniuk, W., Fozard, J. R., Humphrey, P. P. A., Middlemis, D. N., Mylecharane, E. J., Richardson, B. P. and Saxena, P. R. (1986) Proposals for the classification and nomenclature of functional receptors of 5-hydroxytryptamine. Neuropharmacology 25: 563-576.
29. Brakeman, P., Lanahan, A., O'Brien, R., Roche, K., Barnes, C., Huganir, R. and Worley, P. (1997) Homer: a protein that selectively binds metabotropic glutamate receptors. Nature 386: 284-286.
30. 2 receptor binding in rat brain. Eur. J. Pharmacol. 109: 421-425.
31. 2 receptors. Life Sci. 42: 2439-2445.
32. 2 receptors and the abundances of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat. Brain Res. 638: 311-324.
33. 2A receptor expression. Neuroreport 6: 901-904.
34. Burnett, P., Chen, C., McGowan, S., Franklin, M. and Harrison, P. (1996) The effects of clozapine and haloperidol on serotonin-1A, -2A and -2C receptor gene expression and serotonin metabolism in the rat forebrain. Neuroscience 73: 531-540.
35. Burns, C. M., Chu, H., Rueter, S. M., Hutchinson, L. K., Canton, H., Sanders-Bush, E. and Emeson, R. B. (1997) Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387: 303-308.
36. 2 receptor mRNA in rat frontal cortex. J. Neurochem. 61: 1270-1276.
37. 2 receptor function in the brain of the guinea pig. Neuropharmacology 32: 249-256.
38. 1C sites. Eur. J. Pharmacol. 191: 93-96.
39. 2A receptor-mediated phosphoinositide (PI) turnover by clozapine in the rat: a comparison to other antipsychotics. Neurosci. Lett. 181: 65-68.
40. 2C receptor produced by alternative splicing. Mol. Pharmacol. 50: 799-807.
41. 2A antagonists. Soc. Neurosci. Abstr. 22: 1778.
42. Chaki, S., Guo, D. F., Yamano, Y., Ohyama, K., Tani, M., Mizukoshi, M., Shirai, H. and Inagami, T. (1994) Role of carboxyl tail of the rat angiotensin II type 1A receptor in agonist-induced internalization of the receptor. Kidney Int. 46: 1492-1495.
43. Chaput, Y., de Montigny, C. and Blier, P. (1986) Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 333: 342-348.
44. 2) receptor binding sites in cerebellar granule neurons: involvement of calcium influx and a calmodulin-dependent pathway. J. Pharmacol. Exp. Ther. 275: 674-680.
45. 2A receptor mRNA and binding sites in various regions of the rat hippocampus. Brain Res. Mol. Brain Res. 32: 348-353.
46. 2B receptor in mouse gut, cardiovascular system, and brain. FEBS Lett. 391: 45-51.
47. 2B receptor-mediated serotonin morpho-genetic functions in mouse cranial neural crest and myocardiac cells. Development 124: 1745-1755.
48. 1c serotonin receptors. Mol. Pharmacol. 42: 627-633.
49. Choudhary, M. S., Craigo, S. and Roth, B. L. (1993) A single point mutation (Phe340->Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors. Mol. Pharmacol. 43: 755-761.
50. 2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding. Mol. Pharmacol. 47: 450-457.
51. Chuang, D.-M., Dillon-Carter, O., Spain, J. W., Laskowski, M. B., Roth, B. L. and Coscia, C. J. (1986) Detection and characterization of beta-adrenergic receptors and adenylate cyclase in coated vesicles isolated from bovine brain. J. Neurosci. 6: 2578-2584.
52. Chuang, T., Iacovelli, L., Sallese, M. and De Blasi, A. (1996) G-protein-coupled receptors: heterologous regulation of homologous desensitization and its implications. Trends Pharmacol. Sci. 17: 416-420.
53. Chun, M., Liyanage, U., Lisanti, M. and Lodish, H. (1994) Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin. Proc. Natl. Acad. Sci. USA 91: 11728-11732.
54. 2 receptors mediating contraction in vascular smooth muscle. J. Pharmacol. Exp. Ther. 218: 421-425.
55. 2 antagonists inhibit serotonin-stimulated phosphatidylinositol metabolism in cerebral cortex. Neuropharmacology 23: 993-996.
56. Conn, P. J., Sanders-Bush, E., Hoffman, B. J. and Hartig, P. R. (1986) A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. Proc. Natl. Acad. Sci. USA 83: 4086-4088.
57. 2B receptor signaling in the rat stomach fundus: dependence on calcium influx, calcium release and protein kinase C. Behav. Brain Res. 73: 289-292.
58. Damke, H. (1996) Dynamin and receptor-mediated endocytosis. FEBS Lett. 389: 48-51.
59. 2 receptors and serotonin-mediated behaviour. Neuropharmacology 24: 947-952.
60. 2 receptor sites. J. Biol. Chem. 260: 7603-7608.
61. 3 muscarinic receptor and G protein. FEBS Lett. 324: 103-108.
62. 2 receptor. Brain Res. Mol. Brain Res. 14: 166-178.
63. Eison, A. S., Eison, M. S., Yocca, F. D. and Gianutsos, G. (1989) Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following norad-renergic or serotonergic denervation. Life Sci. 44: 1419-1427.
64. 2-mediated behavior in the rat following noradrenergic or serotonergic denervation. J. Neural Transm. Gen. Sect. 84: 19-32.
65. 2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia. Hum. Genet. 97: 614-619.
66. Ferguson, S., Barak, L., Zhang, J. and Caron, M. (1996a) G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins. Can. J. Physiol. Pharmacol. 74: 1095-1110.
67. Ferguson, S., Colapietro, A.-M., Barak, L., Menard, L. and Caron, M. (1996b) Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science 271: 363-366.
68. 2A receptor mRNA in P11 cells. Behav. Brain Res. 73: 187-191.
69. 2 receptors in P11 cells. Mol. Pharmacol. 43: 726-733.
70. 2A receptors in P11 cells through a post-transcriptional mechanism requiring activation of protein kinase C. J. Biol. Chem. 269: 31850-31857.
71. Fersht, A. R. (1988) Relationships between apparent binding energies measured in site-directed mutagenesis experiments and energetics of binding and catalysis. Biochemistry 27: 1577-1580.
72. Fersht, A. R., Leatherbarrow, R. J. and Wells, T. N. C. (1987) Structure-activity relationships in engineered proteins: analysis of use of binding energy by linear free energy relationships. Biochemistry 26: 6030-6038.
73. Findlay, D. M., Houssami, S., Lin, H. Y., Myers, D. E., Brady, C. L., Darcy, P. K., Ikeda, K., Martin, T. J. and Sexton, P. M. (1994) Truncation of the porcine calcitonin receptor cytoplasmic tail inhibits internalization and signal transduction but increases receptor affinity. Mol. Endocrinol. 8: 1691-1700.
74. Fink, H., Morgenstern, R. and Oelssner, W. (1984) Clozapine - a serotonin antagonist? Phamacol. Biochem. Behav. 20: 513-517.
75. Fontaine, R. (1993) Novel serotonergic mechanisms and clinical experience with nefazodone. Clin. Neuropharmacol. 16 (Suppl. 3): S45-S50.
76. Gaddum, J. H. and Hameed, K. A. (1954) Drugs which antagonize 5-hydroxytryptamine. Br. J. Pharmacol. 9: 240-248.
77. Gaddum, J. H. and Picarelli, Z. P. (1957) Two kinds of tryptamine receptors. Br. J. Pharmacol. 12: 323-328.
78. Gaddum, J. H., Khan, A., Hathway, D. E. and Stephens, F. F. (1955) Quantitative studies of antagonists for 5-hydroxytryptamine. Q. J. Exp. Physiol. 40: 49-74.
79. 2 receptor using molecular mechanics and molecular dynamics. Med. Chem. Res. 3: 344-356.
80. 2 involvement in the mechanism of action of hallucinogenic agents. Life Sci. 35: 2505-2511.
81. Gonzalez-Calero, G., Martin, M., Cubero, A. and Andres, A. (1990) Bovine brain coated vesicles contain adenosine A1 receptors. Presence of adenylate cyclase coupled to the receptor. J. Neurochem. 55: 106-113.
82. Goodman, O., Krupnick, J., Santini, F., Gurevich, V., Penn, R., Gagnon, A., Keen, J. and Benovic, J. (1996) β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor. Nature 383: 447-450.
83. 2 and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination. J. Neurochem. 62: 2262-2268.
84. 2 binding sites in rat cortex. J. Neural Transm. Suppl. 41: 127-134.
85. 2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice. Br. J. Pharmacol. 83: 235-242.
86. Grady, E., Garland, A., Gamp, P., Lovett, M., Payan, D. and Bunnett, N. (1995) Delineation of the endocytic pathway of substance P and its seven-transmembrane domain NK1 receptor. Mol. Biol. Cell 6: 509-524.
87. 2A receptors in heterologous expression systems. J. Neurochem. 63: 1255-1260.
88. 2 binding sites in the rat cerebral cortex. J. Neural Transm. 59: 9-23.
89. 2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study. Eur. Neuropsychopharmacol. 5: 19-25.
90. Hamm, H. D., Arendt, A., Hargrave, P. A., Koenig, B. and Hofmann, K. P. (1988) Site of G protein binding of rhodopsin mapped with synthetic peptides from the alpha subunit. Science 241: 832-835.
91. Haraguchi, K., Saito, T., Kaneshige, M., Endo, T. and Onaya, T. (1994) Desensitization and internalization of a thyrotrophin receptor lacking the cytoplasmic carboxy-terminal region. J. Mol. Endocrinol. 13: 283-288.
92. 2c receptor antagonists. J. Biol. Chem. 271: 22591-22597.
93. Hazum, E., Koch, Y., Liscovitch, M. and Amsterdam, A. (1985) Intracellular pathways of receptor-bound GnRH agonist in pituitary gonadotropes. Cell Tissue Res. 239: 3-8.
94. Helmeste, D. M. and Tang, S. W. (1983) Unusual acute effects of antidepressants and neuroleptics on S2- serotonergic receptors. Life Sci. 33: 2527-2533.
95. 2C receptor mRNA expression in the spinal cord of rat, cat, monkey and human. Neuroreport 5: 2617-2620.
96. 2C receptor. J. Neurochem. 69: 1138-1144.
97. Hibert, M. F., Trumpp-Kallmeyer, S., Bruinvels, A. and Hoflack, J. (1991) Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. Mol. Pharmacol. 40: 8-15.
98. Hollister, L. E. (1962) Drug-induced psychoses and schizophrenic reactions, a critical comparison. Ann. NY Acad. Sci. 96: 80-88.
99. 2A receptor model. Arch. Pharm. (Weinheim) 328: 577-584.
100. Horstman, D. A., Brandon, S., Wilson, A. L., Guyer, C. A., Cragoe, E. J., Jr. and Limbird, L. E. (1990) An aspartate conserved among G-protein receptors confers allosteric regulation of alpha 2-adrenergic receptors by sodium. J. Biol. Chem. 265: 21590-21595.
101. Hoyer, D., Clarke, D., Fozard, J., Hartig, P., Martin, G., Mylecharane, E., Saxena, P. and Humphrey, P. (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46: 157-203.
102. Huang, Z., Chen, Y. and Nissenson, R. A. (1995) The cytoplasmic tail of the G-protein-coupled receptor for parathyroid hormone and parathyroid hormone-related protein contains positive and negative signals for endocytosis. J. Biol. Chem. 270: 151-156.
103. Hunyady, L., Bor, M., Balla, T. and Catt, K. J. (1994) Identification of a cytoplasmic Ser-Thr-Leu motif that determines agonist-induced internalization of the ATI angiotensin receptor. J. Biol. Chem. 269: 31378-31382.
104. Hunyady, L., Zhang, M., Jagadeesh, G., Bor, M., Balla, T. and Catt, K. J. (1996) Dependence of agonist activation on a conserved apolar residue in the third intracellular loop of the ATI angiotensin receptor. Proc. Natl. Acad. Sci. USA 93: 10040-10045.
105. Hyde, E., Gray, J. A., Gelber, E. I., Kroeze, W. K. and Roth, B. (1997) Novel techniques for probing receptor-G protein interactions: G-protein affinity chromatography and i3-ELISA. Soc. Neurosci. Abstr. 23: 128.
106. 2 receptors in P11 cells. J. Pharmacol. Exp. Ther. 259: 423-429.
107. Johnson, M. P., Loncharich, R. J., Baez, M. and Nelson, D. L. (1994) Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines. Mol. Pharmacol. 45: 277-286.
108. 2A receptors reveal conserved transmembrane homology to the human rather than rat sequence. Biochim. Biophys. Acta 1236: 201-206.
109. Julius, D., MacDermott, A. B., Axel, R. and Jessell, T. M. (1988) Molecular characterization of a functional cDNA encoding the serotonin 1c receptor. Science 241: 558-564.
110. 2 receptors in human platelets via a mechanism involving protein kinase C. J. Pharmacol. Exp. Ther. 255: 305-311.
111. 2 receptor-stimulated intracellular calcium mobilization in C6BU-1 glioma cells via a mechanism involving a calmodulin pathway. J. Neurochem. 61: 1050-1056.
112. 2 receptor from a human to a rat pharmacology. FEBS Lett. 307: 324-328.
113. Kellar, K. J., Cascio, C. S., Butler, J. A. and Kurtzke, R. N. (1981) Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain. Eur. J. Pharmacol. 69: 515-518.
114. Kendall, D. A., Stancel, G. M. and Enna, S. J. (1982) The influence of sex hormones on antidepressant-induced alterations in neurotransmitter receptor binding. J. Neurosci. 2: 354-360.
115. Kjelsberg, M. A., Cotecchia, S., Ostrowski, J., Caron, M. G. and Lefkowitz, R. J. (1992) Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J. Biol. Chem. 267: 1430-1433.
116. 2 receptors in the rat brain. J. Psychiatry Neurosci. 19: 63-67.
117. 6 serotonin receptor. J. Neurochem. 66: 47-56.
118. 2 receptors. Eur. J. Pharmacol. 164: 595-598.
119. 2C receptor interactions. Eur. J. Pharmacol. 306: 195-210.
120. 2 receptor. Med. Chem. Res. 3: 370-385.
121. 2 receptor density induced by repeated treatment with 5-HT uptake inhibitor or 5-HT agonist. Yakubutsu Seishin Kodo 9: 289-292.
122. 2C receptors in the rat choroid plexus after acute clozapine treatment. Eur. J. Pharmacol. 269: 201-208.
123. 2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs. Neuropsychopharmacology 13: 139-150.
124. 2F) from rat stomach fundus. Mol. Pharmacol. 42: 549-557.
125. 2B receptor. Mol. Pharmacol. 46: 227-234.
126. 2C receptors in the rat choroid plexus. Neuropsychopharmacology 15: 143-151.
127. Labrecque, J., Fargin, A., Bouvier, M., Chidiac, P. and Dennis, M. (1995) Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells. Mol. Pharmacol. 48: 150-159.
128. Lameh, J., Philip, M., Sharma, Y. K., Moro, O., Ramachandran, J. and Sadee, W. (1992) Hm1 muscarinic cholinergic receptor internalization requires a domain in the third cytoplasmic loop. J. Biol. Chem. 267: 13406-13412.
129. Laporte, S. A., Servant, G., Richard, D. E., Escher, E., Guillemette, G. and Leduc, R. (1996) The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization. Mol. Pharmacol. 49: 89-95.
130. 2A receptor and its mRNA in a subpopulation of rat striatal neurons. J. Neurosci. 16: 3727-3736.
131. 2B receptor. J. Biol. Chem. 271: 3141-3147.
132. Lefkowitz, R., Cotecchia, S., Samama, P. and Costa, T. (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 14: 303-307.
133. 2 receptors, roles and regulation. Ann. NY Acad. Sci. 600: 183-191. Discussion: 192-193.
134. Leysen, J. E., Niemegeers, C. J., Tollenaere, J. P. and Laduron, P. M. (1978) Serotonergic component of neuroleptic receptors. Nature 272: 168-171.
135. Leysen, J. E., Van Gompel, P., Gommeren, W., Woestenborghs, R. and Janssen, P. A. (1986) Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone. Psychopharmacology (Berl.) 88: 434-444.
136. 2 receptors by DOM treatment. Eur. J. Pharmacol. 163: 145-149.
137. Li, S., Okamoto, T., Chun, M., Sargiacomo, M., Casanova, J. E., Hansen, S. H., Nishimoto, I. and Lisanti, M. P. (1995) Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J. Biol. Chem. 270: 15693-15701.
138. Lohse, M. J., Benovic, J. L., Codina, J., Caron, M. G. and Lefkowitz, R. J. (1990) beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science 248: 1547-1550.
139. Lohse, M. J., Andexinger, S., Pitcher, J., Trukawinski, S., Codina, J., Faure, J. P., Caron, M. G. and Lefkowitz, R. J. (1992) Receptor-specific desensitization with purified proteins. Kinase dependence and receptor specificity of beta-arrestin and arrestin in the beta 2-adrenergic receptor and rhodopsin systems. J. Biol. Chem. 267: 8558-8564.
140. Loric, S., Maroteaux, L., Kellermann, O. and Launay, J. M. (1995) Functional serotonin-2B receptors are expressed by a teratocarcinoma-derived cell line during serotoninergic differentiation. Mol. Pharmacol. 47: 458-466.
141. Luby, E. D., Cohen, B. D., Rosenbaum, F. and Domino, E. F. (1959) Study of a new schizophreniomimetic drug Sernyl. AMA Arch. Neurol. Psychiatry 81: 363-369.
142. Luby, E. D., Gottlieb, J. S., Cohen, B. D., Rosenbaum, G. and Domino, E. F. (1962) Model psychosis and schizophrenia. Am. J. Psychiatry 119: 61-65.
143. 2A receptor gene and the antipsychotic response to clozapine. Am. J. Psychiatry 153: 1092-1094.
144. 2 antagonists have antidepressant-like effects on differential reinforcement of low-rate 72-second schedule. J. Pharmacol. Exp. Ther. 250: 52-59.
145. 3H]glutamate binding sites in bovine brain coated vesicles. Eur. J. Pharmacol. 207: 215-224.
146. Martin, M., Sanz, J. M. and Cubero, A. (1993) Characterization of metabotropic glutamate receptors coupled to a pertussis toxin sensitive G-protein in bovine brain coated vesicles. FEBS Lett. 316: 191-196.
147. 2 receptor density in rat cerebral cortex. Life Sci. 45: 1397-1406.
148. Matz, R., Rick, W., Oh, D., Thompson, H. and Gershon, S. (1974) Clozapine - a potential antipsychotic agent without extrapyramidal manifestations. Curr. Ther. Res. Clin. Exp. 16: 687-695.
149. Mayer, S. E. and Sanders-Bush, E. (1994) 5-Hydroxytryptamine type 2A and 2C receptors linked to Na+/K+/Cl- cotransport. Mol. Pharmacol. 45: 991-996.
150. 2 receptors in rat brain. Neuropsychopharmacology 2: 81-87.
151. McKenna, D. J., Repke, D. B., Lo, L. and Peroutka, S. J. (1990) Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes. Neuropharmacology 29: 193-198.
152. -2 and serotonin2 pKi values. J. Pharmacol. Exp. Ther. 251: 238-246.
153. 2 receptor number. Eur. J. Pharmacol. 126: 159-162.
154. Mikuni, M. and Meltzer, H. Y. (1984) Reduction of serotonin-2 receptors in rat cerebral cortex after subchronic administration of imipramine, chlorpromazine, and the combination thereof. Life Sci. 34: 87-92.
155. 3 sites in rat brain. Jpn. J. Pharmacol. 47: 107-113.
156. Moereels, H. and Janssen, P. (1993) Molecular modeling of G-protein coupled receptors: going step by step. Med. Chem. Res. 3: 335-343.
157. 1c receptor is a prominent serotonin receptor subtype in the central nervous system. Proc. Natl. Acad. Sci. USA 86: 6793-6797.
158. Moorman, J. and Leslie, R. (1996) p-Chloroamphetamine induces C-fos in rat brain: a study of serotonin2A/2C receptor function. Neuroscience 72: 129-139.
159. 2 receptor-mediated rat aorta contraction: participation of Ca+ + channels and phospholipase C. J. Pharmacol. Exp. Ther. 234: 442-446.
160. 2A receptor and response to clozapine [letter; comment]. Lancet 346: 908-909.
161. Nussenzveig, D. R., Heinflink, M. and Gershengorn, M. C. (1993) Agonist-stimulated internalization of the thyrotropin-releasing hormone receptor is dependent on two domains in the receptor carboxyl terminus. J. Biol. Chem. 268: 2389-2392.
162. 2A receptor determines effector coupling specificity. J. Neurochem. 64: 1440-1447.
163. 2 receptors and their signal system present in coated vesicles prepared from bovine striatal tissue. J. Neurochem. 62: 582-591.
164. 2C receptor. Psychopharmacology (Berl.) 126: 234-240.
165. 2 receptor mediated phosphatidyl inositol hydrolysis by serotonin agonists in quiescent calf aortic smooth muscle cells. Life Sci. 47: 2009-2019.
166. Pazos, A., Hoyer, D. and Palacios, J. M. (1984a) Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors. Eur. J. Pharmacol. 106: 531-538.
167. Pazos, A., Hoyer, D. and Palacios, J. M. (1984b) The binding of serotonergic ligands to the procine choroid plexus: characterization of a new type of serotonin recognition site. Eur. J. Pharmacol. 106: 539-546.
168. Pazos, A., Cortes, R. and Palacios, J. M. (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res. 346: 231-249.
169. Pazos, A., Probst, A. and Palacios, J. M. (1987a) Serotonin receptors in the human brain-III. Autoradiographic mapping of serotonin-1 receptors. Brain Res. 346: 205-230.
170. Pazos, A., Probst, A. and Palacios, J. M. (1987b) Serotonin receptors in the human brain-IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 21: 123-139.
171. Peroutka, S. J. and Snyder, S. H. (1979) Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol. Pharmacol. 16: 687-699.
172. Peroutka, S. J. and Snyder, S. H. (1980a) Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210: 88-90.
173. 2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline. J. Pharmacol. Exp. Ther. 215: 582-587.
174. Peroutka, S. J., Synder, S. H., Peroutka, S. J. and Snyder, S. H. (1980) Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency. Am. J. Psychiatry 137: 1518-1522.
175. 1C cortical receptors. Naunyn Schmiedebergs Arch. Pharmacol. 346: 4-11.
176. Prado, G. N., Taylor, L. and Polgar, P. (1997) Effects of intracellular tyrosine residue mutation and carboxyl terminus truncation on signal transduction and internalization of the rat bradykinin B2 receptor. J. Biol. Chem. 272: 14638-14642.
177. 2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist. Biochem. Pharmacol. 42: 1099-1105.
178. 1C receptors by serotonergic drugs in the rat. Gen. Pharmacol. 25: 1279-1284.
179. 1C/2 receptor agonists and antagonists. Eur. J. Pharmacol. 244: 1-5.
180. Pritchett, D. B., Bach, A. W., Wozny, M., Taleb, O., DalTaso, R., Shih, J. C. and Seeburg, P. H. (1988) Structure and functional expression of a cloned rat serotonin 5-HT-2 receptor. EMBO J. 7: 4135-4140.
181. 2A receptor mRNA levels in rat brain following irreversible inactivation with EEDQ. Brain Res. Mol. Brain Res. 39: 198-206.
182. Rapport, M. M., Green, A. A. and Page, I. H. (1948) Crystalline serotonin. Science 108: 329-331.
183. 2 receptors. Eur. J. Pharmacol. 89: 325-326.
184. 2 receptors in mouse brain. Mol. Pharmacol. 43: 84-89.
185. 2 receptor antagonist. J. Biol. Chem. 269: 396-401.
186. Robinson, D. S., Alms, D. R., Shrotriya, R. C., Messina, M. and Wickramaratne, P. (1989) Serotonergic anxiolytics and treatment of depression. Psychopathology 22 (Suppl. 1): 27-36.
187. Roettger, B., Rentsch, R., Pinon, D., Holicky, E., Hadac, E., Larkin, J. and Miller, L. (1995) Dual pathways of internalization of the cholecystokinin receptor. J. Cell Biol. 128: 1029-1041.
188. Roettger, B., Ghanekar, D., Rao, R., Toledo, C., Yingling, J., Pinon, D. and Miller, L. (1997) Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor. Mol. Pharmacol. 51: 357-362.
189. 2 receptors in rat brain. Gen. Pharmacol. 25: 851-856.
190. 2 receptor function in smooth muscle. In: Serotonin: From Cell Biology to Pharmacology and Therapeutics, pp. 33-38, Paoletti, R., VanHoutte, P. M., Brunello, N. and Maggi, F. M. (eds.) Kluwer Academic Press, Dordrecht.
191. Roth, B. L. (1994) Multiple serotonin receptors: clinical and experimantal aspects. Ann. Clin. Psychiatry 6: 67-78.
192. Roth, B. L. and Chuang, D.-M. (1987) Minireview: multiple mechanisms of serotonergic signal transduction. Life Sci. 41: 1051-1064.
193. 2 receptor mRNA levels. Eur. J. Pharmacol. 207: 169-172.
194. Roth, B. L. and Meltzer, H. Y. (1994) The role of serotonin in schizophrenia. In: Psychopharmacology: The Fourth Generation of Progress, pp. 1215-1227, Bloom, F. E. and Kupfer, D. J. (eds.) Raven Press, New York.
195. Roth, B. L., Nakaki, T., Chuang, D.-M. and Costa, E. (1984) Aortic recognition sites for serotonin (5-HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover. Neuropharmacology 23: 1223-1225.
196. 2 receptors coupled to phospholipase C in rat aorta: modulation of phosphoinositide turnover by phorbol ester. J. Pharmacol. Exp. Ther. 238: 480-485.
197. Roth, B. L., McLean, S., Zhu, X. Z. and Chuang, D. M. (1987) Characterization of two [3H]ketanserin recognition sites in rat striatum. J. Neurochem. 49: 1833-1838.
198. 1c mRNA and receptor levels. Brain Res. Dev. Brain Res. 58: 51-58.
199. 1c receptors. J. Pharmacol. Exp. Ther. 260: 1361-1365.
200. 2 serotonin receptors: what does an analysis of many mutant receptors tell us? Med. Chem. Res. 3: 297-305.
201. Roth, B. L., Craigo, S. C., Choudhary, M. S., Uluer, A., Monsma, F. J., Jr., Shen, Y., Meltzer, H. Y. and Sibley, D. R. (1994) Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther. 268: 1403-1410.
202. 2A) receptor desensitization can occur without down-regulation. J. Pharmacol. Exp. Ther. 275: 1638-1646.
203. Roth, B. L., Tandra, S., Burgess, L. H., Sibley, D. R. and Meltzer, H. Y. (1995b) D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs. Psychopharmacology (Berl.) 120: 365-368.
204. 2A receptors: evidence in favor of a modified ternary complex model. J. Pharmacol. Exp. Ther. 280: 576-583.
205. 2A receptors. Mol. Pharmacol. 52: 259-267.
206. 2 receptor gene regulation in rat myometrial smooth muscle cells. Mol. Cell. Endocrinol. 92: 253-259.
207. 1C receptor subtypes. Biochem. Biophys. Res. Commun. 181: 1469-1478.
208. Samama, P. P., Costa, T., Cotecchia, S. and Lefkowitz, R. J. (1994) Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor. Mol. Pharmacol. 45: 390-394.
209. Schertler, G. and Hargrave, P. (1995) Projection structure of frog rhodopsin in two crystal forms. Proc. Natl. Acad. Sci. USA 92: 11578-11582.
210. 2A receptors in antipsychotic activity. Life Sci. 56: 2209-2222.
211. 2B serotonin receptor. FEBS Lett. 342: 85-90.
212. Schoups, A. A. and De Potter, W. P. (1988) Species dependence of adaptations at the pre- and postsynaptic serotonergic receptors following long-term antidepressant drug treatment. Biochem. Pharmacol. 37: 4451-4460.
213. Schulein, R., Liebenhoff, U., Muller, H., Birnbaumer, M. and Rosenthal, W. (1996) Properties of the human arginine vasopressin V2 receptor after site-directed mutagenesis of its putative palmitoylation site. Biochem. J. 313: 611-616.
214. 2A receptor. J. Biol. Chem. 270: 16683-16688.
215. Serrano, L., Bycroft, M. and Fersht, A. R. (1991) Aromatic-aromatic interactions and protein stability: investigation by double mutant cycles. J. Mol. Biol. 218: 465-475.
216. Shapiro, M. J., Trejo, J., Zeng, D. and Coughlin, S. R. (1996) Role of the thrombin receptor's cytoplasmic tail in intracellular trafficking. Distinct determinants for agonist-triggered versus tonic internalization and intracellular localization. J. Biol. Chem. 271: 32874-32880.
217. Silva, W., Andres, A., Schook, W. and Puszkin, S. (1986) Evidence for the presence of muscarinic acetylcholine receptors in bovine brain coated vesicles. J. Biol. Chem. 261: 14788-14796.
218. Slice, L. W., Wong, H. C., Sternini, C., Grady, E. F., Bunnett, N. W. and Walsh, J. H. (1994) The conserved NPXnY motif present in the gastrin-releasing peptide receptor is not a general sequestration sequence. J. Biol. Chem. 269: 21755-21761.
219. Stefan, C. J. and Blumer, K. J. (1994) The third cytoplasmic loop of a yeast G-protein-coupled receptor controls pathway activation, ligand discrimination, and receptor internalization. Mol. Cell. Biol. 14: 3339-3349.
220. Sterne-Marr, R. and Benovic, J. (1995) Regulation of G protein-coupled receptors by receptor kinases and arrestins. Vitam. Horm. 51: 193-234.
221. Strader, C. D., Sigal, I. S., Candelore, M. R., Rands, E., Hill, W. S. and Dixon, R. A. F. (1988) Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function. J. Biol. Chem. 263: 10267-10271.
222. 2 antagonists with potential atypical antipsychotic activity: antipsychotic profile of iloperidone (HP 873). J. Med. Chem. 38: 1119-1131.
223. Summer, B. E. and Fink, G. (1995) Estrogen increases the density of 5-hydroxytryptamine(2A) receptors in cerebral cortex and nucleus accumbens in the female rat. J. Steroid Biochem. Mol. Biol. 54: 15-20.
224. 2 receptors following chronic treatment with amperozide. J. Recept. Res. 13: 379-392.
225. Tehrani, M. G. and Barnes, E. M., Jr. (1993) Identification of GABAA/benzodiazepine receptors on calthrin-coated vesicles from rat brain. J. Neurochem. 60: 1755-1761.
226. Thomas, W. G., Thekkumkara, T. J., Motel, T. J. and Baker, K. M. (1995) Stable expression of a truncated AT1A receptor in CHO-K1 cells. The carboxyl-terminal region directs agonist-induced internalization but not receptor signaling or desensitization. J. Biol. Chem. 270: 207-213.
227. Thomas, W., Baker, K., Motel, T. and Thekkumkara, T. (1996) Angiotensin II receptor endocytosis involves two distinct regions of the cytoplasmic tail. A role for residues on the hydrophobic face of a putative amphipathic helix. J. Biol. Chem. 270: 22153-22159.
228. 2 receptor mediated c-fos gene expression. Eur. J. Pharmacol. 290: 263-266.
229. 2 receptor as a site-of-action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology 94: 213-216.
230. Tolbert, L. and Lameh, J. (1996) Human muscarinic cholinergic receptor Hm1 internalizes via clathrin-coated vesicles. J. Biol. Chem. 271: 17335-17342.
231. Toth, M. and Shenk, T. (1994) Antagonist-mediated down-regulation of 5-hydroxytryptamine type 2 receptor gene expression: modulation of transcription. Mol. Pharmacol. 45: 1095-1100.
232. Trumpp-Kallmeyer, S., Hoflack, J., Bruinvels, A. and Hibert, M. (1992) Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. J. Med. Chem. 35: 3448-3462.
233. Twist, E. C., Mitchell, S. N., Corn, T. H. and Campbell, I. C. (1991) Effect of chronic ritanserin or clorgyline on amine and metabolite levels in rat frontal cortex. Eur. J. Pharmacol. 196: 157-160.
234. Ullmer, C., Schmuck, K., Kalkman, H. O. and Lubbert, H. (1995) Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett. 370: 215-221.
235. 2B receptor-mediated calcium release from ryanodine-sensitive intracellular stores in human pulmonary artery endothelial cells. Br. J. Pharmacol. 117: 1081-1088.
236. 2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J. Neurosci. 17: 2785-2795.
237. Valiquette, M., Bonin, H., Hnatowich, M., Caron, M. G., Lefkowitz, R. J. and Bouvier, M. (1990) Involvement of tyrosine residues located in the carboxyl tail of the human beta 2-adrenergic receptor in agonist-induced down-regulation of the receptor. Proc. Natl. Acad. Sci. USA 87: 5089-5093.
238. Van Koppen, C. J., Sell, A., Lenz, W. and Jakobs, K. H. (1994) Deletion analysis of the m4 muscarinic acetylcholine receptor. Molecular determinants for activation of but not coupling to the Gi guanine-nucleotide-binding regulatory protein regulate receptor internalization. Eur. J.Biochem. 222: 525-531.
239. von Zastrow, M. and Kobilka, B. (1994) Antagonist-dependent and -independent steps in the mechanism of adrenergic receptor internalization. J. Biol. Chem. 269: 18448-18452.
240. 2 and thrombin receptor desensitization. J. Biol. Chem. 270: 4813-4821.
241. 2B receptor: evidence for species differences. J. Pharmacol. Exp. Ther. 276: 720-727.
242. 2 receptor: identification of amino acids necessary for ligand binding and receptor activation. Mol. Pharmacol. 43: 931-940.
243. 2 receptor does not prevent receptor coupling to phosphoinositide hydrolysis. J. Neurochem. 62: 934-943.
244. Weinstein, H. and Zhang, D. (1995) Receptor models and ligand-induced responses: new insights for structure-activity relations. In: QSAR and Molecular Modelling: Concepts, pp. 497-507, Sanz, F., Giraldo, J. and Manaut, F. (eds.) Prous Science Publishers, Barcelona.
245. Westkaemper, R. B. and Glennon, R. A. (1991) Approaches to molecular modeling studies and specific application to serotonin ligands and receptors. Pharmacol. Biochem. Behav. 40: 1019-1031.
246. 2C receptors. Med. Chem. Res. 3: 317-335.
247. Westphal, R. S. and Sanders-Bush, E. (1994) Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists. Mol. Pharmacol. 46: 937-942.
248. Westphal, R. S., Backstrom, J. R. and Sanders-Bush, E. (1995) Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization. Mol. Pharmacol. 48: 200-205.
249. Wilcox, B. D., Rydelek-Fitzgerald, L. and Jeffrey, J. J. (1992) Regulation of collagenase gene expression by serotonin and progesterone in rat uterine smooth muscle cells. J. Biol. Chem. 267: 20752-20757.
250. 2A receptors. Soc. Neurosci. Abstr. 23: 972.
251. 2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse 27: 79-82.
252. Wooley, D. W. and Shaw, E. (1954) A biochemical and pharmacological suggestion about certain mental disorders. Proc. Natl. Acad. Sci. USA 40: 228-231.
253. Wu, C., Butz, S., Ying, Y. and Anderson, R. (1997) Tyrosine kinase receptors concentrated in caveolae-like domains from neuronal plasma membrane. J. Biol. Chem. 272: 3554-3559.
254. 2 receptor: a mechanistic hypothesis from molecular dynamics simulations of the three-dimensional model of the receptor complexed to ligands. J. Med. Chem. 36: 934-938.
255. Zhang, J., Ferguson, S. S. G., Barak, L. S., Menard, L. and Caron, M. G. (1996) Dynamin and beta-arrestin reveal distinct mechanisms for G protein-coupled receptor internalization. J. Biol. Chem. 271: 18302-18305.
256. Zhou, W., Flanagan, C., Ballesteros, J. A., Konvicka, K., Davidson, J. S., Weinstein, H., Miller, R. P. and Sealfon, S. C. (1994) A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. Mol. Pharmacol. 45: 165-170.